LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for ...

The Interventional Oncology Market is poised for significant growth, projected to reach USD 3.9 billion by 2025, expanding at ...

The ablation technology market is propelled by rising chronic disease burdens and demand for minimally invasive solutions, ...

A British patient who underwent a world-pioneering procedure for multiple lung cancer nodules at Shanghai East Hospital last ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Discover how scientists program nanomaterials to react to environmental triggers, leading to innovations in targeted drug delivery, self-healing materials, and smart electronics.

Pancreatic cancer remains one of the most formidable oncological challenges of our time. Known for its late detection and ...

HistoSonics is shopping for a potential buyer of its approach to destroying liver tumors with focused sound waves, according ...

The goal of the first-in-human proof-of-concept trial is to assess pain reduction via RF ablation. The Company's ...

"When you mix politics and science, you just get politics." -- Former NIH director Francis Collins, MD, PhD, on lessons ...

Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the ...